Citation Impact
Citing Papers
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Thermal Ablation for Benign Thyroid Nodules: Radiofrequency and Laser
2011
LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT2A receptor
2009
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Acromegaly
2006 Standout
The Antitumoral Effects of Somatostatin Analog Therapy in Acromegaly
2005
PlantCARE, a database of plant cis-acting regulatory elements and a portal to tools for in silico analysis of promoter sequences
2002 Standout
Thyroid cancer
2016 Standout
Inhibition of AP-1 by SARI negatively regulates transformation progression mediated by CCN1
2010 Standout
Dopamine Resistance of Prolactinomas
2003
How safe is percutaneous ethanol injection for treatment of thyroid nodule? report of a case of severe toxic necrosis of the larynx and adjacent skin
2004
The Thyroid Nodule
2004 Standout
A 52‐kb deletion in the SOST‐MEOX1 intergenic region on 17q12‐q21 is associated with van Buchem disease in the Dutch population
2002 StandoutNobel
Cushing's syndrome
2015 Standout
A two-solar-mass neutron star measured using Shapiro delay
2010 StandoutNature
Psychedelics
2016 Standout
Paradoxical Enhancement of Pituitary Growth Hormone (GH) Responsiveness to GH-Releasing Factor in the Face of High Somatostatin Tone*
1989
Thyroid Volume and Serum Thyroglobulin Levels in Patients with Acromegaly: Correlation with Plasma Insulin-Like Growth Factor I Levels*
1988
Thyroid Tissue: US-guided Percutaneous Interstitial Laser Ablation—A Feasibility Study
2000
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
2014
Therapeutic Efficacy of the Somatostatin Analog SMS 201-995 (Octreotide) in Acromegaly
1990
Cabergoline in acromegaly: a renewed role for dopamine agonist treatment?
1998
Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions
2008 StandoutNature
Thyroid Imaging Reporting and Data System for US Features of Nodules: A Step in Establishing Better Stratification of Cancer Risk
2011 Standout
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
MEDICAL TREATMENT OF PROLACTINOMAS
1999
TRANSFAC: an integrated system for gene expression regulation
2000
An automated method for finding molecular complexes in large protein interaction networks
2003 Standout
Thyroid Nodules: Clinical Importance, Assessment, and Treatment
2007
Acromegaly
1994
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
2011 Standout
Prolactinoma
2003
Recurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systematic Review and Meta-Analysis
2009
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Epidermal Growth Factor Induces the Functional Expression of Dopamine Receptors in the GH3 Cell Line*
1991
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Cabergoline addition to depot somatostatin analogues in resistant acromegalic patients: efficacy and lack of predictive value of prolactin status
2004
Meta-Analysis on the Effects of Octreotide on Tumor Mass in Acromegaly
2012
Long-term outcome following interstitial laser photocoagulation of benign cold thyroid nodules
2011
Polymorphisms in the Sclerosteosis/van Buchem Disease Gene (SOST) Region Are Associated with Bone-Mineral Density in Elderly Whites
2004 StandoutNobel
Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology
2012 Standout
Accuracy of continuous glucose monitoring during differing exercise conditions
2015
FINE-NEEDLE ASPIRATION BIOPSY OF THE THYROID
2001
GROWTH HORMONE NEUROREGULATION AND ITS ALTERATIONS IN DISEASE STATES
1988
Drug Insight: cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women
2006
Percutaneous Ethanol Injection May be a Definitive Treatment for Symptomatic Thyroid Cystic Nodules not Treatable by Surgery: Five-Year Follow-Up Study
1999
US-Guided Percutaneous Radiofrequency Thermal Ablation for the Treatment of Solid Benign Hyperfunctioning or Compressive Thyroid Nodules
2008
Pituitary Tumor Registry: A Novel Clinical Resource1
2000
TRANSFAC(R): transcriptional regulation, from patterns to profiles
2003 Standout
Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum
2011 Standout
Effect of Ultrasound-Guided Interstitial Laser Photocoagulation on Benign Solitary Solid Cold Thyroid Nodules: One versus Three Treatments
2006
The 2017 Bethesda System for Reporting Thyroid Cytopathology
2017 Standout
Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement
2014 Standout
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
2016 Standout
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
2017 Standout
Percutaneous Ethanol Injection Treatment in Benign Thyroid Lesions: Role and Efficacy
2004
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Endocrine Therapy of Breast and Prostate Cancer
1989
Beneficial Effects of High Daily Dose Bromocriptine Treatment in Cushing's Disease.
1992
Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly
2002
Management of Simple Nodular Goiter: Current Status and Future Perspectives
2003
Treatment of Acromegaly with Dopamine Agonists
1992
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
2017 Standout
American Association Of Clinical Endocrinologists, Associazione Medici Endocrinologi, And European Thyroid Association Medical Guidelines For Clinical Practice For The Diagnosis And Management Of Thyroid Nodules
2010 Standout
Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice
1998 Standout
Clinical Manifestations of Acromegaly
1992
The effects of putative 5-hydroxytryptamine receptor active agents ond-amphetamine self-administration in controls and rats with 5,7-dihydroxytryptamine median forebrain bundle lesion
1984
Efficacy of Sonographically Guided Percutaneous Ethanol Injection for Treatment of Thyroid Cysts Versus Solid Thyroid Nodules
2003
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Characterization of the paradoxical growth hormone inhibitory effect of galanin in acromegaly.
1995
Endocrine profile of ergot alkaloids
1977
Neutron star observations: Prognosis for equation of state constraints
2007
On the Mode of the Prolactin Release-Inhibiting Action of the Serotonin Receptor Blockers Metergoline, Methysergide, and Cyproheptadine*
1981
Cabergoline in the Treatment of Acromegaly: A Study in 64 Patients
1998
Rapid Regression of Pituitary Prolactinomas during Bromocriptine Treatment*
1980
Radiofrequency Ablation for the Treatment of Autonomously Functioning Thyroid Nodules
2009
Ultrasound-Guided Percutaneous Ethanol Injection Therapy in Thyroid Cystic Nodules
2004
Advances in the Treatment of Prolactinomas
2006
Long-Term Treatment of Prolactin-Secreting Macroadenomas with Pergolide
2000
Prolactin-Lowering and -Releasing Drugs Mechanisms of Action and Therapeutic Applications
1983
Diagnosis and treatment of the solitary thyroid nodule. Results of a European survey
1999
Effect of Percutaneous Ethanol Injection TherapyVersusSuppressive Doses ofl -Thyroxine on Benign Solitary Solid Cold Thyroid Nodules: A Randomized Trial1
1998
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Treatment of Large Cold Benign Thyroid Nodules Not Eligible for Surgery with Percutaneous Ethanol Injection
1998
Multiphoton Absorbing Materials: Molecular Designs, Characterizations, and Applications
2008 Standout
Dopamine-receptor agonists: Mechanisms underlying autoreceptor selectivity
1985 StandoutNobel
Role of Dopamine in the Regulation of Growth Hormone Secretion: Dopamine and Bromocriptine Augment Growth Hormone (GH)-Releasing Hormone-Stimulated GH Secretion in Normal Man
1987
Bromocriptine
1977
Cancer treatment and survivorship statistics, 2019
2019 Standout
Growth Factors and Cancer
1991 StandoutScience
Treatment of Large Cold Benign Thyroid Nodules Not Eligible for Surgery with Percutaneous Ethanol Injection
1998
American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules - 2016 Update Appendix
2016 Standout
Pretreatment with somatostatin analog SMS 201-995 potentiates growth hormone (GH) responsiveness to GH-releasing factor in short children.
1993
Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association
2016 Standout
Bromocriptine
1979
Synthesis, two- and three-photon absorption, and optical limiting properties of fluorene-containing ferrocene derivatives
2005
Demonstration of Enhanced Potency of a Chimeric Somatostatin-Dopamine Molecule, BIM-23A387, in Suppressing Growth Hormone and Prolactin Secretion from Human Pituitary Somatotroph Adenoma Cells
2002
Long-Term Treatment of Prolactin-Secreting Macroadenomas with Pergolide
2000
Guidelines for the management of thyroid cancer
2014 Standout
Dopamine receptor agonists: Mechanisms underlying autoreceptor selectivity II. Theoretical considerations
1985 StandoutNobel
Somatostatin and Somatostatin Analogue (SMS 201-995) in Treatment of Hormone-Secreting Tumors of the Pituitary and Gastrointestinal Tract and Non-Neoplastic Diseases of the Gut
1989
Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline
2012 Standout
Treatment of Recurrent Thyroid Cysts with Ethanol: A Randomized Double-Blind Controlled Trial
2003
Dopamine Receptors: From Structure to Function
1998 Standout
Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
1987 StandoutScience
Nerve growth factor suppresses the transforming phenotype of human prolactinomas.
1993
Thyroid carcinoma
2003 Standout
Responses of Markers of Bone and Collagen Turnover to Exercise, Growth Hormone (GH) Administration, and GH Withdrawal in Trained Adult Males1
2000
Works of G. Verde being referenced
Percutaneous Ethanol Injection (PEI): What Is Its Role in the Treatment of Benign Thyroid Nodules?
1995
Ultrasound guided percutaneous ethanol injection in the treatment of cystic thyroid nodules
1994
Safety of recreational scuba diving in type 1 diabetic patients: The Deep Monitoring programme
2009
Isotopic Scaling in Nuclear Reactions
2001
Cushing’s disease and marked hyperprolactinemia in a patient with a pituitary macroadenoma: effectiveness of bromocriptine treatment
1984
Chronic Treatment of Pathological Hyperprolactinemia and Acromegaly with the New Ergot Derivative Terguride*
1986
Isospin Fractionation in Nuclear Multifragmentation
2000
SIZE REDUCTION OF A PROLACTIN SECRETING ADENOMA DURING LONG‐TERM TREATMENT WITH THE DOPAMINE AGONIST LISURIDE
1980
Using views for retrieving data from extremely heterogeneous databanks.
1997
Shift of the absorption spectrum of organic dyes due to saturation
2000
Effect of the new ergot derivative terguride on plasma PRL and GH levels in patients with pathological hyperprolactinemia or acromegaly
1985
Serum Type III Procollagen Propeptide Levels in Acromegalic Patients*
1986
Low Doses of Dopamine Agonists in the Long-Term Treatment of Macroprolactinomas
1985
EVIDENCE FOR A DOPAMINERGIC ACTIVITY OF METHYSERGIDE IN HUMANS
1977
Medical Treatment of Acromegaly with SMS 201-995, a Somatostatin Analog: A Comparison with Bromocriptine*
1987
Effectiveness.of the dopamine agonist lisuride in the treatment of acromegaly and pathological hyperprolactinemic states
1980
Changes in Growth Hormone (GH) Secretion Induced by Human Pancreatic GH Releasing Hormone-44 in Acromegaly: A Comparison with Thyrotropin-Releasing Hormone and Bromocriptine*
1985
Bromocriptine Does Not Alter Growth Hormone (GH) Responsiveness to GH-Rreleasing Hormone in Accromegaly*
1986
Inhibitory Effect of an Ergoline Derivative, Methergoline, on Growth Hormone and Prolactin Levels in Acromegalic Patients
1976
EFFECT OF DOPAMINE INFUSION ON PLASMA LEVELS OF GROWTH HORMONE IN NONMAL SUBJECTS AND IN AGROMEGALIC PATIENTS
1976